277 related articles for article (PubMed ID: 19021281)
1. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory.
Rezkalla SH; Kloner RA
Catheter Cardiovasc Interv; 2008 Dec; 72(7):950-7. PubMed ID: 19021281
[TBL] [Abstract][Full Text] [Related]
2. Reperfusion injury in acute myocardial infarction: from bench to cath lab. Part II: Clinical issues and therapeutic options.
Monassier JP
Arch Cardiovasc Dis; 2008 Sep; 101(9):565-75. PubMed ID: 19041841
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.
Jaffe R; Dick A; Strauss BH
JACC Cardiovasc Interv; 2010 Jul; 3(7):695-704. PubMed ID: 20650430
[TBL] [Abstract][Full Text] [Related]
4. Management of the no-reflow phenomenon.
Butler MJ; Chan W; Taylor AJ; Dart AM; Duffy SJ
Pharmacol Ther; 2011 Oct; 132(1):72-85. PubMed ID: 21664376
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous coronary intervention and the no-reflow phenomenon.
van Gaal WJ; Banning AP
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):715-31. PubMed ID: 17605650
[TBL] [Abstract][Full Text] [Related]
6. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
[TBL] [Abstract][Full Text] [Related]
7. [Acute coronary ischemic syndrome without ST elevation. Role of glycoprotein IIB/IIIA inhibitors and percutaneous coronary interventions].
Peña Duque MA
Arch Cardiol Mex; 2006; 76 Suppl 2():S249-51. PubMed ID: 17017111
[TBL] [Abstract][Full Text] [Related]
8. New strategies for the management of no-reflow after primary percutaneous coronary intervention.
Niccoli G; Cosentino N; Spaziani C; Minelli S; Fracassi F; Crea F
Expert Rev Cardiovasc Ther; 2011 May; 9(5):615-30. PubMed ID: 21615325
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic intragraft injection of nicardipine prior to saphenous vein graft percutaneous intervention for the prevention of no-reflow: a review and comparison to protection devices.
Habibzadeh MR; Thai H; Movahed MR
J Invasive Cardiol; 2011 May; 23(5):202-6. PubMed ID: 21562350
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical interventions for the management of no-reflow.
Fischell TA
J Invasive Cardiol; 2008 Jul; 20(7):374-9. PubMed ID: 18599901
[TBL] [Abstract][Full Text] [Related]
11. Myocardial 'no-reflow' prevention.
Magro M; Springeling T; van Geuns RJ; Zijlstra F
Curr Vasc Pharmacol; 2013 Mar; 11(2):263-77. PubMed ID: 23506503
[TBL] [Abstract][Full Text] [Related]
12. Coronary no reflow.
Schwartz BG; Kloner RA
J Mol Cell Cardiol; 2012 Apr; 52(4):873-82. PubMed ID: 21712046
[TBL] [Abstract][Full Text] [Related]
13. The pathogenesis and treatment of no-reflow occurring during percutaneous coronary intervention.
Movahed MR; Butman SM
Cardiovasc Revasc Med; 2008; 9(1):56-61. PubMed ID: 18206640
[TBL] [Abstract][Full Text] [Related]
14. Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.
J E; Juneja MS; George T; Sr R; V V; Ak B; Kalyani S; Pandurangi UM; Latchumanadhas K; S MA
Indian Heart J; 2007; 59(3):246-9. PubMed ID: 19124934
[TBL] [Abstract][Full Text] [Related]
15. The no-reflow phenomenon: epidemiology, pathophysiology, and therapeutic approach.
Alfayoumi F; Srinivasan V; Geller M; Gradman A
Rev Cardiovasc Med; 2005; 6(2):72-83. PubMed ID: 15976730
[TBL] [Abstract][Full Text] [Related]
16. No-reflow phenomenon: maintaining vascular integrity.
Kloner RA
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):244-50. PubMed ID: 21821523
[TBL] [Abstract][Full Text] [Related]
17. Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning.
Parikh KH; Chag MC; Shah KJ; Shah UG; Baxi HA; Chandarana AH; Naik AM; Shah JN; Shah HD; Goyal RK
Can J Physiol Pharmacol; 2007; 85(3-4):476-82. PubMed ID: 17612657
[TBL] [Abstract][Full Text] [Related]
18. Nicardipine and adenosine "flush cocktail" to prevent no-reflow during rotational atherectomy.
Fischell TA; Haller S; Pulukurthy S; Virk IS
Cardiovasc Revasc Med; 2008; 9(4):224-8. PubMed ID: 18928946
[TBL] [Abstract][Full Text] [Related]
19. [No-reflow phenomenon in the practice of an endovascular surgeon].
Gerasimov AM; Tereshchenko AS; Merkulov EV; Samko AN
Vestn Rentgenol Radiol; 2014; (1):51-5. PubMed ID: 25276888
[TBL] [Abstract][Full Text] [Related]
20. [Study of no-reflow phenomenon after reperfusion for acute myocardial infarction].
Yang YJ; Zhao JL
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(31):2169-70. PubMed ID: 16321176
[No Abstract] [Full Text] [Related]
[Next] [New Search]
